Literature DB >> 16982884

B cells drive early T cell autoimmunity in vivo prior to dendritic cell-mediated autoantigen presentation.

Jun Yan1, Bohdan P Harvey, Renelle J Gee, Mark J Shlomchik, Mark J Mamula.   

Abstract

Both B cells and dendritic cells (DCs) have been implicated as autoantigen-presenting cells in the activation of self-reactive T cells. However, most self-proteins are ubiquitously and/or developmentally expressed, making it difficult to determine the source and the exposure of autoantigens to APCs in a controlled manner. In this study, we have used an Ig transgenic mouse model to examine the mechanisms by which B cells and other APCs acquire and present lupus autoantigens in vivo. Targeting a lupus autoantigen, the small nuclear ribonucleoprotein particle D protein, to the BCR activates autoreactive T cells in the periphery. Our in vivo studies demonstrate that autoantigen-specific B cells, when present in the repertoire, are the first subset of APCs to capture and present self-proteins for activating T cells. Thereafter, DCs acquire self-Ag and become effective APCs for stimulating the same subsets of autoreactive T cells. This mechanism provides one explanation of how early steps in autoimmunity can focus responses, via BCR, at a small group of self-proteins among the total milieu of intracellular self-proteins. Subsequently, DCs and other professional APCs may then amplify and perpetuate the autoimmune T cell response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982884     DOI: 10.4049/jimmunol.177.7.4481

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4(+) T helper type 1 subset differentiation.

Authors:  Caroline L Wilson; Dominic W Hine; Ariel Pradipta; Jeffrey P Pearson; Willem van Eden; John H Robinson; Andrew M Knight
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

Review 2.  B cells in glomerulonephritis: focus on lupus nephritis.

Authors:  Menna R Clatworthy; Kenneth G C Smith
Journal:  Semin Immunopathol       Date:  2007-10-18       Impact factor: 9.623

Review 3.  Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors.

Authors:  Sean R Christensen; Mark J Shlomchik
Journal:  Semin Immunol       Date:  2007-02-02       Impact factor: 11.130

4.  Autoreactive helper T cells alleviate the need for intrinsic TLR signaling in autoreactive B cell activation.

Authors:  Josephine R Giles; Adriana Turqueti Neves; Ann Marshak-Rothstein; Mark J Shlomchik
Journal:  JCI Insight       Date:  2017-02-23

Review 5.  B cells as effectors and regulators of sex-biased arthritis.

Authors:  David Luckey; Kay Medina; Veena Taneja
Journal:  Autoimmunity       Date:  2012-08       Impact factor: 2.815

6.  Transient depletion of CD4+ CD25+ regulatory T cells results in multiple autoimmune diseases in wild-type and B-cell-deficient NOD mice.

Authors:  Jason S Ellis; Xiaoxiao Wan; Helen Braley-Mullen
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

7.  Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1.

Authors:  Chuanlin Ding; Li Wang; Jose Marroquin; Jun Yan
Journal:  Blood       Date:  2008-07-31       Impact factor: 22.113

Review 8.  Murine models of chronic graft-versus-host disease: insights and unresolved issues.

Authors:  Yu-Waye Chu; Ronald E Gress
Journal:  Biol Blood Marrow Transplant       Date:  2008-02-13       Impact factor: 5.742

9.  Repopulation of B-lymphocytes with restricted gene expression using haematopoietic stem cells engineered with lentiviral vectors.

Authors:  T E Taher; C Tulone; R Fatah; F D'Acquisto; D J Gould; R A Mageed
Journal:  Gene Ther       Date:  2008-03-20       Impact factor: 5.250

Review 10.  CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential.

Authors:  E Kondo; L Gryschok; N Klein-Gonzalez; S Rademacher; M R Weihrauch; T Liebig; A Shimabukuro-Vornhagen; M Kochanek; A Draube; M S von Bergwelt-Baildon
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.